Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observing the Changes of Fibroblast Growth Factor 23 in Patients of Tumor Induced Osteomalacia

NCT01660308 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT01660308
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01660308 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observing the Changes of Fibroblast Growth Factor 23 in Patients of Tumor Induced Osteomalacia
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2011
Completion date
August 31, 2016
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypophosphatemia